Avantax Advisory Services Inc. Grows Stock Holdings in Tilray Inc (NASDAQ:TLRY)

Avantax Advisory Services Inc. increased its stake in Tilray Inc (NASDAQ:TLRY) by 23.1% during the 4th quarter, HoldingsChannel reports. The firm owned 121,854 shares of the company’s stock after buying an additional 22,838 shares during the period. Avantax Advisory Services Inc.’s holdings in Tilray were worth $162,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also added to or reduced their stakes in TLRY. Bank of Montreal Can lifted its position in Tilray by 0.3% during the third quarter. Bank of Montreal Can now owns 2,176,506 shares of the company’s stock valued at $3,787,000 after purchasing an additional 7,406 shares in the last quarter. Newman Dignan & Sheerar Inc. boosted its stake in Tilray by 61.9% in the 4th quarter. Newman Dignan & Sheerar Inc. now owns 26,150 shares of the company’s stock worth $35,000 after purchasing an additional 10,000 shares during the period. KBC Group NV grew its stake in Tilray by 75.9% during the fourth quarter. KBC Group NV now owns 38,332 shares of the company’s stock valued at $51,000 after acquiring an additional 16,539 shares in the last quarter. Jones Financial Companies Lllp boosted its stake in Tilray by 125.7% during the fourth quarter. Jones Financial Companies Lllp now owns 31,725 shares of the company’s stock valued at $42,000 after buying an additional 17,670 shares during the last quarter. Finally, Pallas Capital Advisors LLC grew its holdings in shares of Tilray by 59.4% in the fourth quarter. Pallas Capital Advisors LLC now owns 50,438 shares of the company’s stock valued at $67,000 after purchasing an additional 18,792 shares in the last quarter. Institutional investors own 9.35% of the company’s stock.

Tilray Trading Up 9.0 %

TLRY stock opened at $0.71 on Friday. Tilray Inc has a 12 month low of $0.58 and a 12 month high of $2.97. The firm’s 50-day moving average is $0.87 and its 200 day moving average is $1.27. The company has a market capitalization of $669.49 million, a PE ratio of -2.38 and a beta of 2.13. The company has a debt-to-equity ratio of 0.10, a current ratio of 2.54 and a quick ratio of 1.58.

Tilray (NASDAQ:TLRY) last issued its earnings results on Friday, January 10th. The company reported ($0.10) EPS for the quarter, missing analysts’ consensus estimates of ($0.03) by ($0.07). The company had revenue of $210.90 million for the quarter, compared to analysts’ expectations of $216.34 million. Tilray had a negative return on equity of 4.40% and a negative net margin of 30.95%. The firm’s revenue was up 8.7% compared to the same quarter last year. On average, research analysts anticipate that Tilray Inc will post -0.2 EPS for the current year.

Analyst Upgrades and Downgrades

Separately, Canaccord Genuity Group upped their price objective on Tilray from $2.00 to $3.00 and gave the company a “buy” rating in a research report on Monday, January 13th. Three investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, Tilray has a consensus rating of “Hold” and a consensus price target of $2.70.

Tilray Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.